KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 86 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $5,230,000 | -0.3% | 556,383 | +3.2% | 0.00% | 0.0% |
| Q3 2016 | $5,245,000 | +47.2% | 539,090 | +1.6% | 0.00% | 0.0% |
| Q2 2016 | $3,562,000 | -22.4% | 530,816 | +3.2% | 0.00% | 0.0% |
| Q1 2016 | $4,589,000 | -33.4% | 514,428 | -1.0% | 0.00% | 0.0% |
| Q4 2015 | $6,888,000 | +28.3% | 519,864 | +2.0% | 0.00% | 0.0% |
| Q3 2015 | $5,369,000 | -57.4% | 509,882 | +10.0% | 0.00% | -50.0% |
| Q2 2015 | $12,615,000 | -3.1% | 463,627 | +9.1% | 0.00% | 0.0% |
| Q1 2015 | $13,012,000 | +58.7% | 425,106 | +94.0% | 0.00% | +100.0% |
| Q4 2014 | $8,200,000 | +66.4% | 219,078 | +55.4% | 0.00% | 0.0% |
| Q3 2014 | $4,927,000 | -20.7% | 141,013 | +5.7% | 0.00% | 0.0% |
| Q2 2014 | $6,213,000 | +148.4% | 133,469 | +64.9% | 0.00% | – |
| Q1 2014 | $2,501,000 | -11.8% | 80,963 | -34.5% | 0.00% | -100.0% |
| Q4 2013 | $2,834,000 | – | 123,666 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,773,474 | $2,376,456 | 1.12% |
| AlphaCentric Advisors LLC | 1,125,000 | $1,507,500 | 0.86% |
| Tejara Capital Ltd | 1,077,388 | $1,443,700 | 0.82% |
| Palo Alto Investors LP | 5,675,876 | $7,605,674 | 0.72% |
| Birchview Capital, LP | 571,832 | $766,255 | 0.65% |
| Altium Capital Management LP | 740,000 | $991,600 | 0.52% |
| Avidity Partners Management LP | 8,298,570 | $11,120,084 | 0.45% |
| Worth Venture Partners, LLC | 445,981 | $597,615 | 0.36% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 561,955 | $753,020 | 0.23% |
| DAFNA Capital Management LLC | 192,678 | $258,189 | 0.08% |